LECO opens new separation science facility
LECO has opened a new separation science R&D facility in St. Joseph, Michigan, USA, the Elizabeth S. Warren Technical Centre.
LECO has opened a new separation science R&D facility in St. Joseph, Michigan, USA, the Elizabeth S. Warren Technical Centre.
Named after the LECO Executive Vice President and Treasurer Elizabeth S. Warren, the 28,000 square-foot facility is dedicated to the research and development of instrumentation and equipment for LECO’s separation science product line.
The building features laboratory and office areas and an auditorium for presentations and educational forums. Next door is LECO’s main R&D facility, which shares several engineering and technical groups with the new building.
The new building also creates more space in the adjacent Carl E. Schultz Technical Centre for Research and Development. By moving Separation Science R&D to its own building, the existing technical centre now has more room to focus on the continued development of products for LECO’s inorganic, organic and metallographic product lines. The added space in both buildings will enable a more efficient engineering process from start to finish.
For more information please visit ref="http://www.leco.com">www.leco.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
